0
13
Journal Articles about Pharmacotherapy Showing 201-220 of 2221
Reviews and Overviews | October 01, 2005
Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials
Andrea Cipriani, M.D.; Heather Pretty, M.L.I.S.; Keith Hawton, D.Sc.; John R. Geddes, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1805-1819
PDFPDF
Article | October 01, 2005
Morphology of the Anterior Cingulate Gyrus in Patients With Schizophrenia: Relationship to Typical Neuroleptic Exposure
Alison Kopelman, M.D.; Nancy C. Andreasen, M.D., Ph.D.; Peg Nopoulos, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1872-1878
PDFPDF
Article | October 01, 2005
Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia
Alan Breier, M.D.; Paul H. Berg, M.S.; Jogin H. Thakore, M.D.; Dieter Naber, M.D.; Wagner F. Gattaz, M.D.; Patrizia Cavazzoni, M.D.; Daniel J. Walker, Ph.D.; Suraja M. Roychowdhury, Ph.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1879-1887
PDFPDF
Article | October 01, 2005
Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term Trial
Philip D. Harvey, Ph.D.; Jonathan Rabinowitz, Ph.D.; Marielle Eerdekens, M.D.; Michael Davidson, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1888-1895
PDFPDF
Brief Report | September 01, 2005
Double-Blind, Placebo-Controlled Investigation of Amantadine for Weight Loss in Subjects Who Gained Weight With Olanzapine
Karen A. Graham, M.Sc., M.D.; Hongbin Gu, Ph.D.; Jeffrey A. Lieberman, M.D.; Joyce B. Harp, M.D.; Diana O. Perkins, M.D., M.P.H.
The American Journal of Psychiatry. 2005 September ; 9(162):1744-1746
PDFPDF
Brief Report | September 01, 2005
Effects of Antipsychotic Treatment on Emotion Perception Deficits in First-Episode Schizophrenia
Ellen S. Herbener, Ph.D.; S. Kristian Hill, Ph.D.; Robert W. Marvin, M.D.; John A. Sweeney, Ph.D.
The American Journal of Psychiatry. 2005 September ; 9(162):1746-1748
PDFPDF
Brief Report | August 01, 2005
Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia
George M. Simpson, M.D.; Peter Weiden, M.D.; Theresa Pigott, M.D.; Stephen Murray, M.D., Ph.D.; Cynthia O. Siu, Ph.D.; Steven J. Romano, M.D.
The American Journal of Psychiatry. 2005 August ; 8(162):1535-1538
PDFPDF
Article | July 01, 2005
Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial
Mauricio Tohen, M.D., Dr.P.H.; Waldemar Greil, M.D.; Joseph R. Calabrese, M.D.; Gary S. Sachs, M.D.; Lakshmi N. Yatham, M.B., F.R.C.P.C.; Bruno Müller Oerlinghausen, Dr.Med.; Athanasios Koukopoulos, M.D.; Giovanni B. Cassano, M.D.; Heinz Grunze, M.D.; Rasmus W. Licht, M.D., Ph.D.; Liliana Dell’Osso, M.D.; Angela R. Evans, Ph.D.; Richard Risser, M.Sc.; Robert W. Baker, M.D.; Heidi Crane, M.S.; Martin R. Dossenbach, M.D.; Charles L. Bowden, M.D.
The American Journal of Psychiatry. 2005 July ; 7(162):1281-1290
PDFPDF
Article | July 01, 2005
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
Joseph R. Calabrese, M.D.; Paul E. Keck, Jr., M.D.; Wayne Macfadden, M.D.; Margaret Minkwitz, Ph.D.; Terence A. Ketter, M.D.; Richard H. Weisler, M.D.; Andrew J. Cutler, M.D.; Robin McCoy, R.N.; Ellis Wilson, M.S.; Jamie Mullen, M.D.; The BOLDER Study Group
The American Journal of Psychiatry. 2005 July ; 7(162):1351-1360
PDFPDF
Brief Report | July 01, 2005
Generalizability of Antidepressant Efficacy Trials: Differences Between Depressed Psychiatric Outpatients Who Would or Would Not Qualify for an Efficacy Trial
Mark Zimmerman, M.D.; Iwona Chelminski, Ph.D.; Michael A. Posternak, M.D.
The American Journal of Psychiatry. 2005 July ; 7(162):1370-1372
PDFPDF
Images in Psychiatry | June 01, 2005
Melancholia
Gordon Parker, M.D., Ph.D., D.Sc., F.R.A.N.Z.C.P.
The American Journal of Psychiatry. 2005 June ; 6(162):1066-1066
PDFPDF
Article | June 01, 2005
Relationship Between Release of Platelet/Endothelial Biomarkers and Plasma Levels of Sertraline and N-Desmethylsertraline in Acute Coronary Syndrome Patients Receiving SSRI Treatment for Depression
Victor L. Serebruany, M.D., Ph.D.; Raymond F. Suckow, Ph.D.; Thomas B. Cooper, M.D.; Christopher M. O’Connor, M.D.; Alex I. Malinin, M.D.; K. Ranga R. Krishnan, M.D.; Louis T. van Zyl, M.D., M.Med.; Vladimir Lekht, M.D.; Alexander H. Glassman, M.D.; Sertraline Antidepressant Heart Attack Randomized Trial
The American Journal of Psychiatry. 2005 June ; 6(162):1165-1170
PDFPDF
Brief Report | June 01, 2005
Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications
David Straker, D.O.; Christoph U. Correll, M.D.; Elisse Kramer-Ginsberg, Ph.D.; Nasreen Abdulhamid, D.O.; Fiju Koshy, D.O.; Elayna Rubens, M.D.; Robert Saint-Vil, D.O.; John M. Kane, M.D.; Peter Manu, M.D.
The American Journal of Psychiatry. 2005 June ; 6(162):1217-1221
PDFPDF
Brief Report | June 01, 2005
Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder
Joaquim Soler, Psy.D.; Juan Carlos Pascual, M.D.; Josefa Campins, Psy.D.; Judith Barrachina, Psy.D.; Dolors Puigdemont, M.D.; Enrique Alvarez, M.D., Ph.D.; Victor Pérez, M.D., Ph.D.
The American Journal of Psychiatry. 2005 June ; 6(162):1221-1224
PDFPDF
Article | May 01, 2005
Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment
Shitij Kapur, M.D., Ph.D.; Tamara Arenovich, M.S.; Ofer Agid, M.D.; Robert Zipursky, M.D.; Stacy Lindborg, Ph.D.; Barry Jones, M.D.
The American Journal of Psychiatry. 2005 May ; 5(162):939-946
PDFPDF
Article | May 01, 2005
Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial
Nina Schooler, Ph.D.; Jonathan Rabinowitz, Ph.D.; Michael Davidson, M.D.; Robin Emsley, M.D.; Philip D. Harvey, Ph.D.; Lili Kopala, M.D.; Patrick D. McGorry, M.D.; Ilse Van Hove, M.Sc.; Marielle Eerdekens, M.D.; Wim Swyzen, M.D.; Goedele De Smedt, M.D.; the Early Psychosis Global Working Group
The American Journal of Psychiatry. 2005 May ; 5(162):947-953
PDFPDF
Article | May 01, 2005
A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain
David C. Henderson, M.D.; Paul M. Copeland, M.D.; Tara B. Daley, M.P.H.; Christina P. Borba, M.P.H.; Corrine Cather, Ph.D.; Dana D. Nguyen, Ph.D.; Pearl M. Louie, M.D.; A. Eden Evins, M.D.; Oliver Freudenreich, M.D.; Doug Hayden, M.A.; Donald C. Goff, M.D.
The American Journal of Psychiatry. 2005 May ; 5(162):954-962
PDFPDF
Brief Report | May 01, 2005
Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels
Rikus Knegtering, M.D., Ph.D.; Pepijn Baselmans, M.D.; Stynke Castelein, M.Sc.; Fokko Bosker, M.Sc., Ph.D.; Richard Bruggeman, M.D., Ph.D.; Robert J. van den Bosch, M.D., Ph.D.
The American Journal of Psychiatry. 2005 May ; 5(162):1010-1012
PDFPDF
Article | April 01, 2005
Predictors of Antidepressant Use Among Older Adults: Have They Changed Over Time?
Dan G. Blazer, M.D., Ph.D.; Celia F. Hybels, Ph.D.; Gerda G. Fillenbaum, Ph.D.; Carl F. Pieper, Dr.P.H.
The American Journal of Psychiatry. 2005 April ; 4(162):705-710
PDFPDF
Brief Report | April 01, 2005
Is Combination Olanzapine and Antidepressant Medication Associated With a More Rapid Response Trajectory Than Antidepressant Alone?
Gordon Parker, M.D., Ph.D., D.Sc., F.R.A.N.Z.C.P.; Heather Brotchie, B.A., M.B., B.S.; Kay Parker, B.A. (Hons. Psych.)
The American Journal of Psychiatry. 2005 April ; 4(162):796-798
PDFPDF
Copyright ©
American
Psychiatric
Association